Bain Capital Life Sciences Opportunities III LP 13D and 13G filings for Cabaletta Bio, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-08-22 6:10 pm Purchase | 2024-08-12 | 13G | Cabaletta Bio, Inc. CABA | Bain Capital Life Sciences Opportunities III LP | 2,760,888 5.700% | 760,888 (+38.04%) | Filing |
| 2024-02-13 6:47 pm Unchanged | 2023-12-31 | 13G | Cabaletta Bio, Inc. CABA | Bain Capital Life Sciences Opportunities III LP | 2,000,000 4.700% | 0 (Unchanged) | Filing |
| 2023-06-01 4:45 pm Purchase | 2023-05-22 | 13G | Cabaletta Bio, Inc. CABA | Bain Capital Life Sciences Opportunities III LP | 2,000,000 5.000% | 2,000,000 (New Position) | Filing |